(1) Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada

(1) Department of Cardiology, Aarhus University Hospital, Skejby, Denmark; (2) Institute of Cardiology and Center of Excellence on Aging, ‘G. d’Annunzio’ University – Chieti and ”G. Monasterio” Foundation, Pisa, Italy; (3) 3rd Department of Internal Medicine, Cardiology and Emergency Medicine, Wilhelminenhospital, Vienna, Austria; (4) Division of Cardiovascular Medicine and Gill Heart Institute, University of Kentucky, Lexington, Kentucky, USA; (5) Herz-Zentrum Bad Krozingen, Bad Krozingen, Germany

(1) Department of Internal Medicine, Academic Medical Center, Amsterdam, the Netherlands; (2) Department of Anesthesiology, Academic Medical Center, Amsterdam, the Netherlands; (3) Department of Vascular Medicine, University Medical Center Groningen, Groningen, the Netherlands; (4) BayerHealthCare AG, Wuppertal, Germany; (5) Department of Vascular Medicine, Academic Medical Center, Amsterdam, the Netherlands

(1) Cardiovascular Department, Intermountain Medical Center, Salt Lake City, Utah, USA; (2) Division of Genetic Epidemiology, Department of Medicine, University of Utah, Salt Lake City, Utah, USA; (3) Department of Internal Medicine, Washington University in St. Louis, St. Louis, Missouri, USA; (4) Department of Medical Sciences, Clinical Pharmacology, Uppsala University, Uppsala, Sweden; (5) Center for Medical Statistics and Health Evaluation, University of Liverpool, Liverpool, UK; (6) Departments of Medicine and of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; (7) Center for Cardiovascular Disease Prevention, Harvard Medical School, Boston, Massachusetts, USA; (8) Division of Preventive Medicine, Harvard Medical School, Boston, Massachusetts, USA; (9) Division of Cardiovascular Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA; (10) Uppsala Clinical Research Center – UCR, Uppsala University Hospital, Uppsala, Sweden; (11) Division of Cardiology, Department of Medicine, University of Utah, Salt Lake City, Utah, USA; (12) Wolfson Center for Personalized Medicine, University of Liverpool, Liverpool, UK; (13) Departments of Neurology and Epidemiology, University of Alabama, Birmingham, Alabama, USA; (14) Division of General Internal Medicine, Department of Medicine, University of Utah, Salt Lake City, Utah, USA; (15) Associated and Regional University Pathologists, Department of Pathology, University of Utah, Salt Lake City, Utah, USA; (16) Center for Human Genetics, Marshfield Clinic Research Foundation, Marshfield, Wisconsin, USA; (17) Division of Clinical Pharmacology, Department of Medicine and Pharmacology, Vanderbilt University, Nashville, Tennessee, USA; (18) Department of Surgery, Marshfield Clinic, Marshfield, Wisconsin, USA; (19) Department of Pathology, Washington University in St. Louis, St. Louis, Missouri, USA; (20) Division of Clinical Pharmacology, Karolinska Institutet, Stockholm, Sweden; (21) Department of Pharmacology and Pharmacogenomics Research Center, Inje University College of Medicine, Busan, Republic of Korea; (22) Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand; (23) Molecular Diagnostic Laboratory, Kaiser Permanente, Denver, Colorado, USA; (24) Department of Pharmacy Practice, St. Louis College of Pharmacy, St. Louis, Missouri, USA; (25) Department of Orthopaedic Surgery, Washington University in St. Louis, St. Louis, Missouri, USA

(1) Cardiology Division, Department of Medicine, Li Ka Shing Faculty of Medicine, the University of Hong Kong, Hong Kong SAR, China; (2) Neurology Division, Department of Medicine, Li Ka Shing Faculty of Medicine, the University of Hong Kong, Hong Kong SAR, China; (3) Department of Community Medicine, Li Ka Shing Faculty of Medicine, the University of Hong Kong, Hong Kong SAR, China; (4) Department of Neurosurgery, Li Ka Shing Faculty of Medicine, the University of Hong Kong, Hong Kong SAR, China

(1) Department of Medicine, University of Western Ontario, London, Ontario, Canada; (2) Division of Hematology, Department of Medicine, University of Western Ontario, London, Ontario, Canada; (3) Department of Epidemiology and Biostatistics, University of Western Ontario, London, Ontario, Canada; (4) London Laboratory Services Group, London Health Sciences Centre (LHSC), London, Ontario, Canada

(1) Daiichi Sankyo Co., Ltd. – Biological Research Laboratories, Tokyo, Japan

(1) Translational Medicine, Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany; (2) Research & Development Project Management, Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany; (3) Department of Drug Metabolism and Pharmacokinetics, Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany; (4) Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, CT, USA; (5) Corporate Department of Medical Affairs, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Germany

(1) Department of Surgery, Uppsala Academic Hospital, Uppsala, Sweden; (2) Department of Surgery, University of Granada, Hospital Virgen de las Nieves, Granada, Spain; (3) Department of Orthopaedic Surgery, Hospital Fernando Fonseca, Amadora, Portugal

(1) Department of Surgery, Uppsala Academic Hospital, Uppsala, Sweden; (2) Department of Surgery, University of Granada, Hospital Virgen de las Nieves, Granada, Spain; (3) Department of Orthopaedic Surgery, Hospital Fernando Fonseca, Amadora, Portugal

(1) Department of Pediatrics, Nara Medical University, Kashihara, Japan

(1) Laboratório de Tecido Conjuntivo, Hospital Universitário Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Cidade Universitária, Ilha do Fundão, Rio de Janeiro, Brazil; (2) Instituto de Bioquímica Médica, Universidade Federal do Rio de Janeiro, Cidade Universitária, Ilha do Fundão, Rio de Janeiro, Brazil; (3) Laboratório de Glicofármacos, Instituto Macaé de Metrologia e Tecnologia, Universidade Federal do Rio de Janeiro, Macaé, Brazil

(1) Laboratoire d’hémobiologie EA4174-IFR62 Faculté de médecine RTH Laennec, Université de Lyon, Lyon, France; (2) Biométhodes, Evry, France; (3) CEA, iBEB, Service de Biochimie et Toxicologie Nucléaire, Bagnols sur Cèze, France; (4) Present address: Global Bioenergies, Evry, France

(1) Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia

(1) University of Pécs, Heart Institute, Division of Interventional Cardiology, Hungary; (2) 3rd Department of Cardiology, Medical University of Silesia, Katowice, Poland; (3) Department of Cardiology, Oslo University Hospital Ullevål and Institute for Clinical Medicine, University of Oslo, Oslo, Norway; (4) HeartDrug™ Research LLC, Johns Hopkins University, Towson, Maryland, USA

(1) Department of Neurology, Poznan University of Medical Sciences, Poznan, Poland; (2) Department of Clinical Immunology, Poznan University of Medical Sciences, Poznan, Poland; (3) Department of Haemostatic Disorders, Medical University of Lodz, Lodz, Poland

(1) Institute for Molecular Cardiovascular Research, RWTH Aachen University, Aachen, Germany; (2) Polyphor Ltd., Allschwil, Switzerland; (3) Institute for Cardiovascular Prevention, Ludwig-Maximilians-University Munich, Munich, Germany

(1) Institute of Transfusion Medicine and Immunohaematology, Department of Molecular Haemostaseology, University Hospital Frankfurt, DRK Blood Donor Service Baden-Württemberg – Hessen, Frankfurt, Germany; (2) Department of Internal Medicine, Division of Vascular Medicine and Haemostaseology, University Hospital Frankfurt, Germany

(1) Hôtel-Dieu University Hospital, Paris, France; (2) Biomnis Laboratories R&D, Ivry-sur-Seine, France; (3) Diagnostica Stago SA, Gennevilliers, France; (4) Bayer HealthCare Pharmaceuticals Inc., Montville, New Jersey, USA; (5) Bayer HealthCare Pharmaceuticals AG, Wuppertal, Germany

(1) Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, USA; (2) Biomarkers, BioCytex, Marseille, France; (3) Biological Research Laboratories, Daiichi Sankyo Company, Ltd., Tokyo, Japan; (4) Cardiovascular-Metabolics Research Laboratories, Daiichi Sankyo Company, Ltd., Tokyo, Japan; (5) Département de Cardiologie Interventionnelle, Polyclinique des Fleurs, Ollioules, France